ABVC BioPharma, Inc. Additional Paid in Capital, Common Stock
ABVC BioPharma, Inc. (ABVC) had Additional Paid in Capital, Common Stock of $78.03 million as of 2024-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2025-08-13
- 2024-06-30: Additional Paid in Capital, Common Stock $78.03M.
- 2024-03-31: Additional Paid in Capital, Common Stock $77.00M.
- 2023-12-31: Additional Paid in Capital, Common Stock $73.98M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2024-06-30 | $78.03M 10-Q · filed 2025-08-13 |
| 2024-03-31 | $77.00M 10-Q · filed 2025-04-30 |
| 2023-12-31 | $73.98M 10-K · filed 2025-04-15 |